These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 12385827
1. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Chapman SC, Bernard DJ, Jelen J, Woodruff TK. Mol Cell Endocrinol; 2002 Oct 31; 196(1-2):79-93. PubMed ID: 12385827 [Abstract] [Full Text] [Related]
2. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W. Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731 [Abstract] [Full Text] [Related]
3. Inhibin binding protein (InhBP/p120), betaglycan, and the continuing search for the inhibin receptor. Bernard DJ, Chapman SC, Woodruff TK. Mol Endocrinol; 2002 Feb 23; 16(2):207-12. PubMed ID: 11818494 [Abstract] [Full Text] [Related]
6. Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). Chapman SC, Woodruff TK. Mol Endocrinol; 2001 Apr 23; 15(4):668-79. PubMed ID: 11266516 [Abstract] [Full Text] [Related]
8. Aberrantly increased mRNA expression of betaglycan, an inhibin co-receptor in the ovarian tissues in women with polycystic ovary syndrome. Zhu R, Zhou X, Chen Y, Qiu C, Xu W, Shen Z. J Obstet Gynaecol Res; 2010 Feb 23; 36(1):138-46. PubMed ID: 20178540 [Abstract] [Full Text] [Related]
13. A Tale of Two Proteins: Betaglycan, IGSF1, and the Continuing Search for the Inhibin B Receptor. Bernard DJ, Smith CL, Brûlé E. Trends Endocrinol Metab; 2020 Jan 23; 31(1):37-45. PubMed ID: 31648935 [Abstract] [Full Text] [Related]
14. Differential expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and activin type-I and type-II receptors in preovulatory and prehierarchical follicles of the laying hen ovary. Lovell TM, Knight PG, Gladwell RT. J Endocrinol; 2006 Feb 23; 188(2):241-9. PubMed ID: 16461550 [Abstract] [Full Text] [Related]
15. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan. Farnworth PG, Wang Y, Escalona R, Leembruggen P, Ooi GT, Findlay JK. Endocrinology; 2007 Nov 23; 148(11):5355-68. PubMed ID: 17656464 [Abstract] [Full Text] [Related]